Phase II clinical trial of cisplatin (CDDP), 5-Fluorouracil (5-FU) and ifosfamide (IFX) as treatment for advanced locoregional head and neck carcinoma (AHNC)

被引：0
|
作者：
Parra, MS
Churruca, C
Paredes, A
Lacasta, A
de Argumedo, GL
Alvarez, I
Abad, T
Egana, L
Iriarte, L
Urraca, JM
Piera, JM
机构：
[1] Hosp No So Aranzazu, Med Oncol Unit, San Sebastian, Spain
[2] Hosp No So Aranzazu, Radiotherapy Unit, San Sebastian, Spain
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
380
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [11] The efficacy and safety of combination chemotherapy with paclitaxel, 5-fluorouracil (5-FU) and cisplatin for advanced gastric carcinoma: A phase II study
    Kim, S.
    Lim, H.
    Lee, H.
    Yuh, Y.
    ANNALS OF ONCOLOGY, 2007, 18 : VII54 - VII55
  • [12] Phase II trial of cisplatin (CDDP), 5-Fluorouracil (5Fu) and folinic acid (FA) for relapsing or metastatic squamous cell cancer of the head and neck (SCCHN)
    Vaz, F
    Oliveira, J
    Ferreira, M
    Torrinha, F
    Fernandes, A
    ANNALS OF ONCOLOGY, 1998, 9 : 79 - 79
  • [13] Results of a randomized phase II trial of docetaxel (TXT) with cisplatin (CDDP) or TXT with 5-fluorouracil (5FU) in patients (pts) with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Biakhov, M
    Betka, J
    Shah, P
    Julka, P
    Garin, A
    Stanculaneu, D
    Kawecki, A
    Miserque, D
    Blanc, C
    ANNALS OF ONCOLOGY, 2000, 11 : 92 - 92
  • [14] A PHASE-I/II TRIAL OF SEQUENTIAL METHOTREXATE (MTX), CIS-PLATINUM (CDDP), 5-FLUOROURACIL (5-FU) INFUSION, AND LEUCOVORIN (L) IN ADVANCED HEAD AND NECK-CANCER
    LESTER, EP
    SHEPARD, KV
    PURVIS, JD
    CLINICAL RESEARCH, 1985, 33 (04): : A854 - A854
  • [15] A phase II study of vinorelbine GIRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Guillem, V
    Muñoz, MA
    Yaya, R
    Soriano, V
    Climent, MA
    Gaspar, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S176 - S176
  • [16] CLINICAL-TRIAL OF CISPLATIN AND 5-FU INFUSION AS INITIAL TREATMENT FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    KISH, J
    DRELICHMAN, A
    JACOBS, J
    HOSCHNER, J
    KINZIE, J
    LOH, J
    WEAVER, A
    ALSARRAF, M
    CANCER TREATMENT REPORTS, 1982, 66 (03): : 471 - 474
  • [17] Phase I-II study with docetaxel (D), cisplatin (C) and 5-Fluorouracil (5-FU) in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Brandely, M
    Vermorken, JB
    ANNALS OF ONCOLOGY, 1998, 9 : 75 - 75
  • [18] ASSOCIATION OF CISPLATIN (CDDP) AND 5-FLUOROURACIL (5-FU) IN THE TREATMENT OF SQUAMOUS-CELL CANCER OF THE METASTATIC LUNG (CSPM) - PHASE-II STUDY
    VENTURINI, M
    NICOSIA, F
    VENTURINI, S
    TROIANI, R
    LOMBARDI, M
    SICARI, A
    SPINELLI, I
    TUMORI, 1986, 72 (06) : 736 - 736
  • [19] A phase I-II study of cisplatin (CDDP) plus tomudex (TOM) plus levofolinic acid (LFA) plus 5-fluorouracil (5-FU) in locally advanced or metastatic head and neck cancer (HN).
    Caponigro, F
    Budillon, A
    Avallone, A
    Rivellini, F
    Di Gennaro, E
    Ionna, F
    Mozzillo, N
    Marcolin, P
    Guida, C
    Comella, P
    Comella, G
    CLINICAL CANCER RESEARCH, 1999, 5 : 3775S - 3775S
  • [20] Phase I-II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Le Bouder, C
    Castelijns, J
    Awada, A
    Vermorken, JB
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S164 - S164
12345